Moderna(MRNA)
Focus: Moderna is a Cambridge-based mRNA therapeutics company with 5,900 employees that has rapidly scaled from a 2010 startup to a public biotech leader generating $6.8B in FY2025 revenue. The company operates across vaccines, oncology, rare diseases, and infectious disease with a platform-driven business model centered on mRNA technology.
Profile data last refreshed 15m ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Employees
5,900
Open Jobs
264+771 this month
Hot — 864 jobs added in 30d
Net +771 (864 new, 93 removed). Aggressive expansion phase.
Should You Work at Moderna?
AI assessmentBest for scientists and engineers seeking exposure to cutting-edge mRNA biology and oncology with platform upside; higher risk for those prioritizing near-term revenue stability or cash flow visibility.
Why Work Here
- Work on a proprietary mRNA platform with proven commercial validation—Spikevax generated $19.3B revenue in FY2024, demonstrating platform viability at scale.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$6.8B
Key Products
GROWTH
Recently approved RSV vaccine in growth phase; represents platform expansion beyond COVID into seasonal vaccine markets.
Help build intelligence for Moderna
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.